FIELD: chemistry.
SUBSTANCE: invention relates to binary diglyceride derivatives of tertiary alkylamines of general formula given below, which can be used as ionisable cationic lipids for designing lipid nanoparticles for RNA delivery into cells and an organism. In said general formula, R denotes an unbranched alkyl residue of fatty acids of the limit series C7H15, C9H19, C11H23; n = 3, 4; m = 1, 3.
EFFECT: invention also relates to a lipid nanoparticle for delivery of RNA into cells and an organism, containing RNA and said binary diglyceride derivatives of tertiary alkylamines, and to its use for delivery and expression of mRNA into cells and an organism.
3 cl, 3 dwg, 2 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
MULTI-EPITOPE POLYPEPTIDE FOR IMMUNIZATION AGAINST MYCOBACTERIUM TUBERCULOSIS | 2023 |
|
RU2824195C1 |
SORAFENIB-BASED COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA | 2022 |
|
RU2800071C1 |
ANTICANCER RNA VACCINES | 2017 |
|
RU2768829C2 |
LIPID NANOPARTICLES FOR IN VIVO MEDICINAL PRODUCTS DELIVERY AND THEIR USE | 2020 |
|
RU2799045C1 |
POLYNUCLEOTIDES CODING INTERLEUKIN-12 (IL12), AND APPLICATIONS THEREOF | 2017 |
|
RU2769316C2 |
COMPOSITIONS OF NON-VIRAL NON-CAPSID DNA VECTORS BASED ON LIPID NANOPARTICLES | 2018 |
|
RU2778407C2 |
LIPID COMPOUND AND COMPOSITION BASED THEREON | 2021 |
|
RU2825571C1 |
RNA PARTICLES INCLUDING POLYSARCOZINE | 2019 |
|
RU2792644C2 |
MODIFIED NUCLEOSIDE, NUCLEOTIDE AND NUCLEIC ACID COMPOSITIONS | 2012 |
|
RU2649364C2 |
mRNA-BASED IMMUNOBIOLOGICAL AGENT FOR PREVENTION OF DISEASES CAUSED BY TICK-BORNE ENCEPHALITIS VIRUS | 2024 |
|
RU2823754C1 |
Authors
Dates
2024-07-22—Published
2023-11-14—Filed